From: Cumulative lactate and hospital mortality in ICU patients
Characteristic | All | Survivors | Nonsurvivors | p valuea |
---|---|---|---|---|
n = 2,251 | n = 1846 | n = 405 | ||
Age (yr) | 66 (12–98) | 69 (57–76) | 75 (67–81) | |
Sex M : F (%) | 61 : 39 | 61 : 39 | 60 : 40 | |
SAPS-II | 38 (20–113) | 33 (24–43) | 51 (41–65) | <0.001* |
SOFA | ||||
APACHE II | 17 (10–54) | 15 (11–19) | 23 (17–28) | <0.001* |
Admission source (%) | <0.01#* | |||
Emergency | 20.2 | 20.4 | 19.3 | |
Surgical / OR | 43.7 | 47.3 | 27.0 | |
Medical | 27.2 | 23.7 | 43.1 | |
CCU | 8.0 | 7.5 | 10.1 | |
Other | 0.9 | 1.1 | 0.5 | |
Diagnosis (%) | <0.01#* | |||
Vascular surgery | 16.0 | 17.2 | 10.4 | |
Abdominal surgery | 22.4 | 23.5 | 17.2 | |
Other surgery | 9.8 | 10.9 | 4.9 | |
Heart failure | 14.8 | 12.3 | 26.4 | |
Respiratory failure | 11.8 | 11.5 | 13.4 | |
GI bleeding | 3.8 | 4.3 | 1.5 | |
Neurological | 4.5 | 4.6 | 2.7 | |
Other | 3.7 | 3.9 | 4.2 | |
Sepsis | 13.1 | 11.8 | 19.2 | |
Vasoactive agent (%) | 33 | 28 | 57 | <0.001* |
LOS ICU (days) | 2 (1–5) | 2 (1–5) | 3 (1–8) | <0.001* |
LOS HOSP (days) | 14 (7–27) | 15 (9–28) | 6 (2–16) | <0.001* |
In-hospital mortality (%) | 18 |